ASCO living guideline (version 2026.1.2) on immunotherapy and targeted therapy for advanced gastroesophageal cancer, updated regularly by a standing expert panel that continuously and systematically reviews the literature. The abstract gives no specific recommendations.
Guideline
Shah et al. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2